Professor Jonathan Baell from MIPS has collaborated with researchers from the Peter MacCallum Cancer Centre to discover a new way to target acute myeloid leukaemia (AML) at its source - a discovery that could yield a more effective
The Monash Institute of Pharmaceutical Sciences has again received excellent results in the latest Excellence in Research for Australia (ERA) rankings.
PharmAlliance, the research, professional practice and education partnership between the Schools of Pharmacy at Monash University, University College London (UCL) and the University of North Carolina at Chapel Hill (UNC), has held its
The Monash Faculty of Pharmacy and Pharmaceutical Sciences has been awarded nearly $20 million dollars in research funding in the recent rounds of grants announced by the National Health and Medical Research Council (“NHMRC”) and the
A world-leading team, led by Professor Jian Li from the Monash Biomedicine Discovery Institute (BDI), has been awarded a multi-million dollar grant
Monash University drug discovery research has led to a change in editorial policy of the world’s largest scientific society, in a move that could save government and industry millions of dollars a year in
A coalition of researchers from Monash University, the University of Melbourne and The Indian Institute of Chemical Biology has been awarded A$1 million in research funding to develop a new treatment for the
8 November 2016
A new class of trypanosomacides has been synthesised by MIPS research teams headed by Professor Jonathan Baell and Dr Raphael Rahmani.
13 September 2016
Monash researchers have discovered that an insulin molecule produced by cone snails may enable the development of faster-acting therapeutic insulin.